
Several barriers continue to impede the transition to value-based payment, particularly administrative and clinical data connectivity, transparency of quality metrics and quality measures, and prioritization of social determinants of health.

Several barriers continue to impede the transition to value-based payment, particularly administrative and clinical data connectivity, transparency of quality metrics and quality measures, and prioritization of social determinants of health.

Deficiencies in immunoglobulin levels frequently coexist with type 1 diabetes (T1D) in pediatric patients according to new study results.

Hospital reimbursement deals slow the adoption of biosimilars in oncology, but cost concerns contribute to the incentives to use these agents.

Nicola Hanania, MD, MS, explains how some patients with chronic obstructive pulmonary disease (COPD) face challenges when it comes to affording treatment for the disease.

Results from a questionnaire-based study indicated an association between a history of abuse and increased sensory hypersensitivity symptoms among migraineurs.

Adverse reactions to the Johnson & Johnson vaccine cause some states to pause distribution; the Biden administration proposes creation of a $6.5 billion medical research agency aiming to cure cancer and other diseases; Pfizer/BioNTech seeks expansion of its COVID-19 vaccine emergency use authorization in adolescents.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Russell Langan, MD, chief of Surgical Oncology and Hepatopancreatobiliary Surgery at Saint Barnabas Medical Center discusses the workflow of a cloud-based data management platform for patients with pancreatic cysts.

The device, which highlights for gastroenterologists regions of the colon that have visual characteristics consistent with possible cancerous abnormalities, is already in use in Europe.

A high proportion of Marshallese, or Marshall Islanders, living on the mainland Unites States, have undiagnosed hypertension and type 2 diabetes (T2D), according to findings that will be used to address disparities in Native Hawaiian and Pacific Islander populations.

The risk for patients with monoclonal gammopathy of undetermined significance developing multiple myeloma is double if they have a specific category of rheumatic diseases compared with those without the diseases.

According to the researchers, the study is the first to describe a relationship between these factors and the development of atopic dermatitis (AD) in infants using multiomics.

The findings illustrate the importance of prioritizing COVID-19 vaccinations for patients on dialysis.

Researchers found that people with Parkinson disease have 53% lower step length synergy while crossing obstacles than those without the condition, potentially providing a target approach to address fall risk in patients.

Given the high prevalence of Kawasaki disease during the pandemic, Japanese investigators determined that droplet or contact transmission of pathogens is likely not a major route causing the development of the disease.

The study identifies the tumor-suppressing protein p53 as a working partner of “speckles,” nuclear structures that contain proteins and RNA involved in gene expression.

The advent of both new diagnostic criteria and treatments have necessitated a reevaluation of fatigue among individuals who have multiple sclerosis, investigators say.

On day 2 of this year’s Community Oncology Conference, a panel of government and health policy experts gathered to discuss the hot-button issue of political influence on cancer policy and the damage community oncology has suffered this past year.

Children who were born to women with a history of asthma had a 45% increased risk of being diagnosed with atopic dermatitis/eczema up to age 8 years.

A recent review took a look at the promise of measuring circulating tumor DNA (ctDNA) with digital-droplet PCR (ddPCR) in pancreatic ductal adenocarcinoma (PDAC) as the landscape of this cancer continues to shift toward personalized, precision treatment.

There are many sources, and definitions, of where the value in cancer care lies. In this panel discussion, a cancer survivor and patient advocate, an oncologist, and a benefits professional provided their perspectives on what value in cancer care means to them.

COVID-19 led many patients to change their use of disease-modifying antirheumatic drugs in the pandemic’s initial months, with or without physician guidance.

A 2021 survey on health care trends to monitor finds provider burnout, disengagement, and shortage of health care professionals as the most potentially disruptive issues facing hospitals and health systems in the next 3 years.

Polymerase chain reaction testing of suspected cases of adenoviral conjunctivitis in a hospital setting resulted in large cost savings by avoiding unnecessary employee furloughs.

Lalan Wilfong, MD, executive vice president, Value Based Care & Quality Programs, Texas Oncology, and cochair, Payment Reform, Community Oncology Alliance, speaks on the evolution of remote monitoring in cancer care and how value-based oncology may look in the near future.

Edward Licitra, MD, PhD, medical oncologist, Astera Health Partners, discusses his thoughts on what value-based cancer care entails and how physicians can best align their goals with those of the patient and health plan.

A machine learning model using the gut microbiome may serve as a successful predictive measure for type 2 diabetes development.

Veterans Affairs data show that among patients with heart failure admitted to skilled nursing facilities, those with delirium exhibited decreased rates of functional recovery.

Approximately 45% of patients with obstructive sleep apnea were shown to present with nonalcoholic fatty liver disease, with age and weight indicated as significant predictors of high fibrosis score risk.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
